Ian Mortimer

Insider Reports History

Entity
Individual
Location
C/O Xenon Pharmaceuticals Inc., 200 3650 Gilmore Way, Burnaby, British Columbia, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian Mortimer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Common Shares 31.3K $308K $9.85 May 24, 2023 Direct
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Common Shares 14.3K $141K $9.85 May 24, 2023 By Spouse.
Xenon Pharmaceuticals Inc. PRESIDENT & CEO, Director Stock Option (Right to Buy) 250K Mar 11, 2024 Direct

Insider Reports Filed by Ian Mortimer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Mar 11, 2024 1 $0 4 Mar 12, 2024 PRESIDENT & CEO, Director
XENE Xenon Pharmaceuticals Inc. May 24, 2023 12 -$1.16M 4 May 26, 2023 PRESIDENT & CEO, Director
XENE Xenon Pharmaceuticals Inc. Mar 10, 2023 1 $0 4 Mar 14, 2023 PRESIDENT & CEO, Director
XENE Xenon Pharmaceuticals Inc. Mar 10, 2022 1 $0 4 Mar 14, 2022 PRESIDENT & CEO, Director
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 PRESIDENT & CEO, Director